文献速递瓣膜外科主动脉外科

冷冻保存主动脉同种移植物治疗复杂性主动脉瓣或根部心内膜炎:28年经验

Cryopreserved aortic homografts for complex aortic valve or root endocarditis: a 28-year experience.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该研究回顾了1993年1月至2021年7月在本机构接受冷冻保存主动脉同种移植物(CAH)行主动脉瓣置换或主动脉根部置换的全部成年患者,共104例,其中心内膜炎94例(90%)。结果显示医院死亡12例(12%),随访期间死亡39例(42%),平均生存时间13.9±1.2年,无再干预生存时间15.7±1.2年。作者认为对于复杂性心内膜炎,CAH行主动脉瓣或根部置换的医院生存率令人满意,无复发性感染生存率极佳,晚期再手术需求与其他生物瓣膜相似。

要点

  • 104例患者中94例(90%)因心内膜炎接受CAH,其中自体瓣膜心内膜炎33例(35%),人工瓣膜心内膜炎61例(65%)。
  • 医院死亡12例(12%),术后低心排血量综合征7例(7%),其中4例需ECMO,3例需IABP。
  • 随访期间死亡39例(42%),平均生存时间13.9±1.2年,无再干预生存时间15.7±1.2年。

核心结论

  • 对于复杂性心内膜炎,使用CAH行主动脉瓣置换或主动脉根部置换,考虑到手术时患者病情危重,医院生存率令人满意,无复发性感染生存率极佳。
  • 术后晚期再手术需求与其他生物瓣膜相似。

研究设计与样本

  • 回顾性分析1993年1月至2021年7月在本机构接受冷冻保存主动脉同种移植物(CAH)行主动脉瓣置换或主动脉根部置换的全部成年患者,共104例。

主要发现

  • 104例患者中男性75例、女性29例,年龄59±17岁;心内膜炎94例(90%),主动脉瓣疾病10例(10%)。
  • 心内膜炎患者中自体瓣膜心内膜炎33例(35%),人工瓣膜心内膜炎61例(65%),环形脓肿77例(82%),二尖瓣心内膜炎13例(14%),三尖瓣心内膜炎13例(14%)。
  • 平均体外循环时间214±80分钟,平均主动脉阻断时间164±56分钟。
  • 医院死亡12例(12%),术后低心排血量综合征7例(7%),其中4例需体外膜肺氧合,3例需主动脉内球囊反搏。
  • 随访期间死亡39例(42%),随访完整率94%;平均生存时间13.9±1.2年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to evaluate early- and long-term outcomes of cryopreserved aortic homograft (CAH) implantation for aortic valve replacement (AVR) or aortic root replacement (ARR) in patients with or without complex infective endocarditis. METHODS: All adult patients undergoing AVR or ARR with CAH at our institution between January 1993 and July 2021 were included in the study. RESULTS: One hundred four patients, 75 males and 29 females, aged 59 ± 17 years, underwent AVR or ARR with CAH for infective endocarditis (n = 94, 90%) or aortic valve disease (n = 10, 10%). There were 33 (35%) native valve endocarditis and 61 (65%) prosthetic valve endocarditis, which were complicated by annular abscess in 77 (82%) patients, mitral valve endocarditis in 13 (14%) and tricuspid valve endocarditis in 13 (14%). The mean cardiopulmonary bypass time was 214 ± 80 min and the mean aortic cross-clamping time was 164 ± 56 min. There were 12 (12%) hospital deaths and 7 (7%) postoperative low cardiac output syndrome requiring extracorporeal membrane oxygenation in 4 patients and intra-aortic balloon pump in 3. Thirty-nine (42%) patients died during the follow-up (94% complete). The mean survival time was 13.9 ± 1.2 years. Twenty-five patients (26%) underwent late reoperation for aortic homograft degeneration (n = 17, 18%), homograft endocarditis (n = 6, 7%), homograft dehiscence (n = 1, 1%) and mitral valve regurgitation (n = 1, 1%). The mean survival free from reintervention was 15.7 ± 1.2 years. CONCLUSIONS: AVR or ARR with a CAH for complex endocarditis is associated with satisfactory hospital survival, considering the critical patient presentation at surgery, and excellent survival free from recurrent infection. Need for reoperation late after surgery is similar to other biological prostheses.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Galeone A, Trojan D, Gardellini J, et al. Cryopreserved aortic homografts for complex aortic valve or root endocarditis: a 28-year experience. Eur J Cardiothorac Surg. 2022. PMID: 35388890. doi:10.1093/ejcts/ezac193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。